Skip to Main Content
1
Smilow Cancer Hospital Care Center - North Haven
6 Devine Street, Fl 1
North Haven, CT 06473
1 of 2
  • Smilow Cancer Hospital Care Center - North Haven
    6 Devine Street, Fl 1
    North Haven, CT 06473
  • Smilow Cancer Hospital at Yale New Haven
    35 Park Street
    New Haven, CT 06511

Kevin Billingsley, MD, MBA, FACS

Surgery, Gastrointestinal Surgical Oncology
Patient type treated
Adult
Accepting new patients
Yes
Referral required
From patients or physicians
Board Certified in
General Surgery

Biography

Dr. Billingsley is a surgical oncologist who specializes in the surgical treatment of gastrointestinal cancers. In his administrative role, Dr. Billingsley serves as the chief medical officer for the Yale Cancer Center and Smilow Cancer Hospitaland Care Centers. 

Dr. Billingsley says he considers caring for cancer patients a privilege and a calling. He most values the relationships he develops with patients and their families through the course of the cancer care journey.  

He treats tumors of the liver, pancreas, gall bladder, and bile ducts, including cholangiocarcinoma. Cholangiocarcinoma is a type of cancer that forms in the bile ducts, which transport fluids and connect the liver to the gallbladder and small intestine. Dr. Billingsley has expertise in metastatic tumors in the liver. 

Dr. Billingsley works closely with medical oncologists, gastroenterologists, interventional radiologists, and other specialists to coordinate care. In his surgical practice, he employs many technical approaches to liver and pancreatic tumor treatment, opting for minimally invasive techniques, including robotic surgery, whenever possible. 

In his role as chief medical officer, Dr. Billingsley oversees quality and patient safety initiatives across the cancer care enterprise. He leads the improvement of multidisciplinary team structures, assists with facilities and space planning, and works closely with Yale New Haven Health System’s clinical leaders.

Dr. Billingsley’s research endeavors have focused on clinical research in gastrointestinal cancer with a particular emphasis on developing new multidisciplinary treatment strategies for metastatic colorectal cancer and improving clinical outcomes following complex liver and pancreas operations. In his leadership role, his interests include the development of integrated academic health care systems, patient communication, and strategies to support clinician resilience. 

Titles

  • Professor of Surgery (Oncology)
  • Chief Medical Officer, Yale Cancer Center

Education & Training

  • MBA
    OHSU/Portland State University, Healthcare Management (2020)
  • Surgical Oncology Fellow
    Memorial Sloan Kettering Cancer Center (1998)
  • Sr. and Chief Resident
    Oregon Health and Science University (1996)
  • Research Fellow
    National Cancer Institute (1994)
  • Resident
    Oregon Health and Science University (1992)
  • Intern
    Oregon Health and Science University (1990)
  • MD
    Johns Hopkins (1989)
  • BS
    Stanford University, Biological Sciences (1985)

Additional Information

Biography

Dr. Billingsley is a surgical oncologist who specializes in the surgical treatment of gastrointestinal cancers. In his administrative role, Dr. Billingsley serves as the chief medical officer for the Yale Cancer Center and Smilow Cancer Hospitaland Care Centers. 

Dr. Billingsley says he considers caring for cancer patients a privilege and a calling. He most values the relationships he develops with patients and their families through the course of the cancer care journey.  

He treats tumors of the liver, pancreas, gall bladder, and bile ducts, including cholangiocarcinoma. Cholangiocarcinoma is a type of cancer that forms in the bile ducts, which transport fluids and connect the liver to the gallbladder and small intestine. Dr. Billingsley has expertise in metastatic tumors in the liver. 

Dr. Billingsley works closely with medical oncologists, gastroenterologists, interventional radiologists, and other specialists to coordinate care. In his surgical practice, he employs many technical approaches to liver and pancreatic tumor treatment, opting for minimally invasive techniques, including robotic surgery, whenever possible. 

In his role as chief medical officer, Dr. Billingsley oversees quality and patient safety initiatives across the cancer care enterprise. He leads the improvement of multidisciplinary team structures, assists with facilities and space planning, and works closely with Yale New Haven Health System’s clinical leaders.

Dr. Billingsley’s research endeavors have focused on clinical research in gastrointestinal cancer with a particular emphasis on developing new multidisciplinary treatment strategies for metastatic colorectal cancer and improving clinical outcomes following complex liver and pancreas operations. In his leadership role, his interests include the development of integrated academic health care systems, patient communication, and strategies to support clinician resilience. 

Titles

  • Professor of Surgery (Oncology)
  • Chief Medical Officer, Yale Cancer Center

Education & Training

  • MBA
    OHSU/Portland State University, Healthcare Management (2020)
  • Surgical Oncology Fellow
    Memorial Sloan Kettering Cancer Center (1998)
  • Sr. and Chief Resident
    Oregon Health and Science University (1996)
  • Research Fellow
    National Cancer Institute (1994)
  • Resident
    Oregon Health and Science University (1992)
  • Intern
    Oregon Health and Science University (1990)
  • MD
    Johns Hopkins (1989)
  • BS
    Stanford University, Biological Sciences (1985)

Additional Information

1
Smilow Cancer Hospital Care Center - North Haven
6 Devine Street, Fl 1
North Haven, CT 06473
1 of 2
  • Smilow Cancer Hospital Care Center - North Haven
    6 Devine Street, Fl 1
    North Haven, CT 06473
  • Smilow Cancer Hospital at Yale New Haven
    35 Park Street
    New Haven, CT 06511